Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sideris Delaroudis"'
Autor:
Thomai Karagiozoglou-Lampoudi, Aikaterina Siopi, Stergios A. Polyzos, Maria F. Vasiloglou, Dimitrios Molyvas, Vassilis Mougios, Christos S. Mantzoros, Andreas Filippaios, Aggeliki Apostolou, Athanasios D. Anastasilakis, Elpida C. Skouvaklidou, Panagiotis Chatzistavridis, Zacharias G. Saridakis, Georgios Kynigopoulos, Grigorios Panagiotou, Sideris Delaroudis
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 99:3247-3255
The myokine irisin may increase energy expenditure and affect metabolism.The objective of the study was to elucidate predictors of irisin and study whether circulating irisin may have day-night rhythm in humans.This was an observational, cross-sectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf930ab347b0b01e4f989fcdb3e10573
https://doi.org/10.1210/jc.2014-1367
https://doi.org/10.1210/jc.2014-1367
Autor:
Athina Gkiomisi, Polyzois Makras, Athanasios D. Anastasilakis, Ilias Bisbinas, Sideris Delaroudis, Spyridon Gerou, Evridiki Papadopoulou, Stergios A. Polyzos, Grigorios T. Sakellariou
Publikováno v:
Clinical Endocrinology. 77:816-822
SummaryObjective Patients treated with intravenous zoledronate frequently experience an acute phase reaction (APR) characterized by flu-like symptoms and increased levels of inflammatory cytokines. We aimed to define the role of various cytokines/adi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d3dd151ac1dfc9c81b7e739fb4f9744
https://doi.org/10.1111/j.1365-2265.2012.04459.x
https://doi.org/10.1111/j.1365-2265.2012.04459.x
Autor:
Athina Gkiomisi, Grigorios T. Sakellariou, Socrates E. Papapoulos, Ilias Bisbinas, Athanasios D. Anastasilakis, Dimitrios Oikonomou, Iris Ballaouri, Stergios A. Polyzos, Polyzois Makras, Spyridon Gerou, Sideris Delaroudis
Publikováno v:
BONE, 50(5), 1130-1134
An acute phase response (APR) is frequently observed in patients treated with intravenous (i.v.) zoledronate (ZOL). We aimed to define clinical and laboratory parameters that may predict ZOL-induced APR in women with low bone mass. Fifty-one postmeno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fc253b45f488a22dd120e7e897cc6d8
https://doi.org/10.1016/j.bone.2012.02.006
https://doi.org/10.1016/j.bone.2012.02.006
Autor:
Zisis Telioudis, Konstantinos Vahtsevanos, C. Magopoulos, Sideris Delaroudis, Konstantinos D. Antoniadis, Georgios Karakinaris, Ioannis Dimitrakopoulos
Publikováno v:
American Journal of Otolaryngology. 28:158-163
Purpose: Bisphosphonates are compounds used in the treatment of various metabolic and malignant bone diseases. In the last two and a half years, there has been a striking increased referral of patients with exposed necrotic jawbone, mostly after seve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1244828662696aa97417b868e0fac6bb
https://doi.org/10.1016/j.amjoto.2006.08.004
https://doi.org/10.1016/j.amjoto.2006.08.004
Publikováno v:
Metabolism: clinical and experimental. 64(10)
Since the identification of osteoporosis as a major health issue in aging populations and the subsequent development of the first treatment modalities for its management, considerable progress has been made in our understanding of the mechanisms cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5002da0fe2e26e8dcea69c4531b2d220
https://pubmed.ncbi.nlm.nih.gov/26277199
https://pubmed.ncbi.nlm.nih.gov/26277199
Autor:
Athanasios D. Anastasilakis, Stergios A. Polyzos, Mattheos Savvides, Sideris Delaroudis, Christos Georgopoulos
Publikováno v:
Journal of Bone and Mineral Metabolism. 28:108-110
Intermittent exogenous parathyroid hormone (PTH) is a potent osteoanabolic agent used for the treatment of severe osteoporosis. Two molecules of recombinant PTH are commercially available: the full-length PTH (PTH 1-84) and teriparatide (PTH 1-34). W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f42737d443a7b0714c812500a3cda42b
https://doi.org/10.1007/s00774-009-0105-3
https://doi.org/10.1007/s00774-009-0105-3
Publikováno v:
Journal of Bone & Mineral Metabolism; Jan2010, Vol. 28 Issue 1, p108-110, 3p